HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation
Elizabeth F. Krakow(Fred Hutch Cancer Center), Marie Bleakley(Unknown), Scott N. Furlan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ted Gooley(Fred Hutch Cancer Center), Philip D. Greenberg(University of Washington), Graeme Black(Fred Hutch Cancer Center), Aude G. Chapuis(University of Washington), Albert C. Yeh(University of Washington), Kyle B. Woodward(Jackson Memorial Hospital), Brian G. Till(University of Washington), Melinda A. Biernacki(Fred Hutch Cancer Center), Ann Dahlberg(Seattle Children's Hospital), Robson G. Dossa(Fred Hutch Cancer Center), Evan W. Newell(Agency for Science, Technology and Research), Michelle Brault(Fred Hutch Cancer Center), Nicole Vartanian(Fred Hutch Cancer Center), Cecilia C.S. Yeung(University of Washington), Merav Bar(Fred Hutch Cancer Center), Sami B. Kanaan(Fred Hutch Cancer Center), Corinne Summers(Seattle Children's Hospital), Ryan D. Cassaday(University of Washington), Tanya Cunningham(Fred Hutch Cancer Center), Andrew Denker, Stanley R. Riddell(Fred Hutch Cancer Center), David G. Maloney(Fred Hutch Cancer Center)
Cited by 29
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k